Covered recipient · General Payments record
JOHN E WALKER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,084.35
- Reported across 251 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $320.39 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $83.96 | 3 |
| PFIZER INC. | $67.33 | 3 |
| Seqirus USA Inc | $44.89 | 2 |
| Novo Nordisk AS | $34.77 | 2 |
| Amgen Inc. | $20.29 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.31 | 1 |
| Lilly USA, LLC | $16.97 | 1 |
| Neos Therapeutics, LP | $16.63 | 1 |
| Acerta Pharma LLC | $16.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.94 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106299447 | CMS |
| ABBVIE INC. | $32.78 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106299449 | CMS |
| ABBVIE INC. | $26.24 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106299451 | CMS |
| Amgen Inc. | $20.29 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117409454 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.24 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105565162 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.31 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117879537 | CMS |
| Lilly USA, LLC | $16.97 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135070965 | CMS |
| Neos Therapeutics, LP | $16.63 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082670095 | CMS |
| Novo Nordisk Inc | $17.68 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096802500 | CMS |
| Novo Nordisk Inc | $17.09 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096997627 | CMS |
| PFIZER INC. | $22.50 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131038336 | CMS |
| PFIZER INC. | $18.59 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131482408 | CMS |
| PFIZER INC. | $26.24 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132110441 | CMS |
| Seqirus USA Inc | $25.86 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125638892 | CMS |
| Seqirus USA Inc | $19.03 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125638894 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.